Deliver Your News to the World

EVERSANA Expands Safety Case Management Capabilities with Oracle

Leading life sciences service provider selects Oracle Argus Cloud Service to gain efficiency, precision, and speed for its pharmacovigilance services


AUSTIN, Texas – WEBWIRE

EVERSANA, a leading provider of global commercial services to the life sciences industry, has selected Oracle Argus Cloud Service as its end-to-end pharmacovigilance services platform. Through the centralized Oracle safety system, EVERSANA will have new tools to streamline safety management, enhance regulatory compliance, and optimize operational efficiency for all global customers.

“Our commitment to our clients is unwavering, and we understand the critical importance of delivering excellence in every aspect of our services, especially in ensuring the safety and well-being of patients,” said Jim Lang, CEO, EVERSANA. “Together with Oracle Argus Cloud Service, we will drive process improvement and increase our safety cases management capabilities with unmatched precision and agility to support patients across the world.”

EVERSANA’s integrated solutions support the global commercialization needs of life sciences and biotech companies throughout the product life cycle. The company’s compliance customers will benefit from the added security and performance of the Oracle Cloud Infrastructure and Oracle Argus Cloud Service, which offers a central location for documenting all data about adverse events including source documents, assessments, and regulatory reports.

The platform is the single source of truth for downstream aggregate analytics and signal detection and will help and EVERSANA to further standardize, streamline, and simplify drug safety operations with built-in automation, workflow optimization, and conditional touchless processing to manage rapidly increasing caseloads and changing regulations.

“As an established leader in life sciences technology, we are committed to delivering next-generation pharmacovigilance solutions that helps the industry address complex challenges around drug safety and post-market surveillance,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “With Oracle Argus Cloud Service, EVERSANA now offers a mature, proven pharmacovigilance solution that can meet the changing industry demands for its clients in safety case management and compliance.”

Oracle Argus Cloud Service offers high availability and comprehensive features and functionalities including AI-enabled automation capabilities, designed to address the complexities of safety management in the life sciences industry—all while delivering ongoing innovation and continuous improvement. Oracle Argus Cloud processes more than ten million cases annually. For more information about Oracle Argus Cloud Service visit: https://www.oracle.com/industries/life-sciences/pharmacovigilance/argus-safety-case-management/

To learn more about EVERSANA and Oracle, click here.

###

About Oracle

Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

About Oracle Life Sciences

Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the Life Sciences industry to improve patient outcomes. Learn more at oracle.com/lifesciences

About EVERSANA

EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X.


( Press Release Image: https://photos.webwire.com/prmedia/6/328013/328013-1.jpg )


WebWireID328013





This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.